News & Events
May 02 2019

NICE Guidance
for High Performing MedTech Products
an Accelerated Access Scheme

['NICE Guidance\r', 'for High Performing MedTech Products\r', 'an Accelerated Access Scheme']

NICE has today published further guidance on how high-performing products will be identified and selected by the Accelerated Access Collaborative (AAC) and how support will be offered to them;


What types of innovations are eligible for support?

Each year, the Accelerated Access Collaborative (AAC) will identify and support innovations that will have the biggest impact on patient outcomes and NHS services. The AAC will consider a full range of innovations across the development pipeline, including – medicines, therapeutic products, medical technologies, digital products and diagnostic products.

The AAC will take a “flexible and pragmatic approach” to identify game-changing innovations which may not be cost-neutral in year but are assessed by NICE to be both clinically and cost-effective.

Areas of interest for the AAC include:

  • evidence of clinical and cost effectiveness
  • addressing significant unmet need
  • application to large populations or high budget impact
  • enabling a novel mode of action or enabling significant changes to the care pathway.

What type of support can a product expect to receive?

Products designated as high potential will receive a tailored package of support, with dedicated case management. The AAC partners and the company will agree this based on their development or accelerated needs.

Want to find out more?

To find out more please contact Device Access here

Since 2010 Device Access UK have supported over 30 MedTech Companies through various NICE Programmes including Interventional Procedures (IPG), MedTech Guidance (MTG) and Diagnostic Assessments (DAP), as well as NICE MedTech Innovation Briefings (MIB)

Most recent
Device Access welcomes Dr. Christopher Pomfrett to the team
February 03 2022
The Benefits and Opportunities of Entering the UK Healthcare Market with MedTech Post-Brexit
July 31 2021
NHS England Announce New Funding Mechanism for Innovative MedTech
January 27 2021
How Changes in NHS Funding May Affect Your MedTech Adoption Journey
November 25 2020
What is NICE Recommendation and Why is it Useful?
July 10 2020
What is MedTech Market Access?
June 04 2020
Planning Your Engagement Strategy with the NHS Post-Covid-19
June 04 2020
“Battle Stations”: MedTech Can Fight Against Unseen Enemies Like Covid-19
April 02 2020
MedTech Industry Engagement with NHS England after Covid-19
March 20 2020
New NHS England MedTech Funding Mandate Proposal – to get innovative medical devices, diagnostics and digital products to patients faster
November 16 2019
Innovative Approach That Gets Patients Back Into Their Own Homes After Hospital Stay Honoured - NHS England
July 25 2019
Health Technology Evaluation Methods
July 23 2019
NHS England Medical Device Reimbursement Opportunities
July 01 2019
NICE Guidance for High Performing MedTech Products an Accelerated Access Scheme
May 02 2019
IGES Institut GmbH Acquires Majority Shareholding in Device Access UK
March 04 2019
NICE Approves New Minimally Invasive Steam Ablation Treatment for Benign Prostatic Hyperplasia
August 21 2018
NHS England is Calling on the Best Innovators from Across the World to Apply to Join New NHS Adoption Scheme to Ensure Patients Benefit from New Technology Faster.
September 14 2018
Contact us